⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4243340 | 0.79 | — | — | |
| SCHEMBL11555341 | 0.77 | — | — | |
| SCHEMBL433690 | 0.77 | — | — | |
| SCHEMBL22638030 | 0.77 | — | — | |
| SCHEMBL18989711 | 0.76 | — | — | |
| SCHEMBL27747937 | 0.75 | ALDH1A1 (0.41) | — | |
| SCHEMBL3490608 | 0.75 | ALDH1A1 (0.37) | — | |
| SCHEMBL4686601 | 0.75 | — | — | |
| SCHEMBL1170252 | 0.74 | — | — | |
| SCHEMBL4038182 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210238210-A1 | ANTIVIRAL COMPOUNDS | VIROVAX LLC | 2021-08-05 | — | — | US | claimed |
| US-20120232169-A1 | HIGHLY MONODISPERSE BRANCHED PEG-LIPID CONJUGATES | BIOZONE PHARMACEUTICALS, INC. (US) | 2012-09-13 | — | — | US | claimed |
| WO-2012122144-A1 | HIGHLY MONODISPERSE BRANCHED PEG-LIPID CONJUGATES | WU NIAN (US) | 2012-09-13 | — | — | WO | claimed |
| US-20090093521-A1 | 2, 5-Bis-Diamine [1,4] Benzoquinone-Derivatives | ALMA MATER STUDIORUM - UNIVERISTA'DI BOLOGNA (IL) | 2009-04-09 | — | — | US | claimed |
| EP-1890995-A2 | SYNTHESIS OF ORGANIC COMPOUNDS | Alma Mater Studiorum -Universita' di Bologna (IT) | 2008-02-27 | — | — | EP | claimed |
| WO-2006134457-A2 | 2,5-BIS-DIAMIMNE [1 , 4] BENZOQUINONE-DERIVATIVES | ALMA MATER STUDIORUM-UNIVERSITA' DI BOLOGNA (IT) | 2006-12-21 | — | — | WO | claimed |
| EP-0770598-B1 | Process for the preparation of carbazates | BAYER AG (DE) | 2001-07-25 | — | — | EP | claimed |
| EP-0770598-A2 | Process for the preparation of carbazates | BAYER AG (DE) | 1997-05-02 | — | — | EP | claimed |
| EP-0665020-A2 | Method for preparing thioether conjugates | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-08-02 | — | — | EP | claimed |
| EP-0530252-A4 | AMINOALKYLCARBAMYL DERIVATIVES OF FORSKOLIN AS INTERMEDIATES FOR THE SYNTHESIS OF USEFUL FORSKOLIN DERIVATIVES | US HEALTH (US) | 1993-09-01 | — | — | EP | claimed |
| EP-0530252-A1 | AMINOALKYLCARBAMYL DERIVATIVES OF FORSKOLIN AS INTERMEDIATES FOR THE SYNTHESIS OF USEFUL FORSKOLIN DERIVATIVES | THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE (US) | 1993-03-10 | — | — | EP | claimed |
| EP-0184550-B1 | 5-AMINO-4-HYDROXY VALERYL AMIDE DERIVATIVES | CIBA-GEIGY AG (CH) | 1992-03-18 | — | — | EP | claimed |
| WO-1991017154-A1 | AMINOALKYLCARBAMYL DERIVATIVES OF FORSKOLIN AS INTERMEDIATES FOR THE SYNTHESIS OF USEFUL FORSKOLIN DERIVATIVES | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) | 1991-11-14 | — | — | WO | claimed |
| EP-0236734-A2 | 5-Amino-4-hydroxyvaleryl derivatives substituted by s-containing groups | CIBA-GEIGY AG (CH) | 1987-09-16 | — | — | EP | claimed |
| EP-0184550-A2 | 5-Amino-4-hydroxy valeryl amide derivatives | CIBA-GEIGY AG (CH) | 1986-06-11 | — | — | EP | claimed |
| JP-9124585-A | — | — | None | — | — | JP | disclosed |
| JP-1316381-A | — | — | None | — | — | JP | disclosed |
| EP-0236734-A2 | 5-Amino-4-hydroxyvaleryl derivatives substituted by s-containing groups | CIBA-GEIGY AG (CH) | 1987-09-16 | — | — | EP | disclosed |
| EP-0210137-A2 | Condensed triazolo compounds | CIBA-GEIGY AG (CH) | 1987-01-28 | — | — | EP | disclosed |
| EP-0184550-A2 | 5-Amino-4-hydroxy valeryl amide derivatives | CIBA-GEIGY AG (CH) | 1986-06-11 | — | — | EP | disclosed |